ANDA 75874, held by Teva Pharms USA. Ifosfamide; Mesna.
As of Nov 15, 2026, ANDA 75874 (Ifosfamide/Mesna Kit), held by Teva Pharms USA, was first approved by FDA on Feb 26, 2002, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 2002 | Original application | Approved | None posted |
| Ifosfamide/Mesna Kit1GM/20ML;1GM/10ML (50MG/ML;100MG/ML) · injectable;intravenous | Ifosfamide; Mesna | Discontinued |
| Ifosfamide/Mesna Kit3GM/60ML;1GM/10ML (50MG/ML;100MG/ML) · injectable;intravenous | Ifosfamide; Mesna | Discontinued |
| May 26, 2015 | Supplement 30Labeling · Standard review | Approved | None posted |
| May 26, 2015 | Supplement 33Labeling · Standard review | Approved | None posted |
| May 26, 2015 | Supplement 37Labeling · Standard review | Approved | None posted |
| Mar 21, 2011 | Supplement 17Labeling | Approved | None posted |
| Jan 17, 2003 | Supplement 6Labeling | Approved | None posted |
| Dec 13, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Feb 26, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters